Diagnosis and Treatment of Mirizzi Syndrome: 23-Year Mayo Clinic Experience

被引:75
|
作者
Erben, Young [1 ]
Benavente-Chenhalls, Luis A. [1 ]
Donohue, John M. [1 ]
Que, Florencia G. [1 ]
Kendrick, Michael L. [1 ]
Reid-Lombardo, Kaye M. [1 ]
Farnell, Michael B. [1 ]
Nagorney, David M. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Gen Surg, Rochester, MN 55905 USA
关键词
LAPAROSCOPIC CHOLECYSTECTOMY; PREOPERATIVE DIAGNOSIS; CLASSIFICATION; FISTULA;
D O I
10.1016/j.jamcollsurg.2011.03.008
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Mirizzi syndrome (MS) is characterized by extrinsic compression of the common hepatic duct by stones impacted in the cystic duct or gallbladder neck. Open cholecystectomy (OC) has been the standard treatment; however, laparoscopy has challenged this approach. STUDY DESIGN: The objective of this study was to review our clinical experience with MS since the introduction of laparoscopic cholecystectomy (LC) and determine the impact of alternative approaches. We conducted a retrospective review of patients with MS from January 1987 to December 2009. RESULTS: There were 36 patients with MS among 21,450 cholecystectomies (frequency 0.18%). Seventeen were women. The most common presenting symptoms were abdominal pain (n = 23) and jaundice (n = 19). Preoperative diagnostic studies included ultrasonography (n = 27), CT (n = 24), and endoscopic retrograde cholangiopancreatography (n = 32). Cholecystectomy was performed in 35 patients; LC was initiated in 15 and OC in 21. Conversion rate from LC to OC was 67%. Five patients who had successful LC had type I MS. Of the patients who underwent LC with conversion or OC, 14 had type I and 16 had type II MS. The cystic duct for type I and the bile duct for type II MS were managed diversely according to surgeon's preference. There was no operative mortality. Morbidity was 31% with Clavien class I in 2, IIIa in 4, IIIb in 1, and IV in 3 patients. Mean hospitalization was 9 days (range 2 to 40 days). Mean follow-up was 37 months (range 1 to 187 months). CONCLUSIONS: Low incidence and nonspecific presentation of MS precludes referral and substantive individual experience. Although LC may be applicable in selected patients with type IMS, OC remains the standard of care. (J Am Coll Surg 2011; 213: 114-121. (C) 2011 by the American College of Surgeons)
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [21] Daratumumab, carfilzomib, pomalidomide and elotuzumab for the treatment of poems syndrome: the Mayo Clinic experience
    Vaxman, Iuliana
    Kumar, Shaji
    Buadi, Francis
    Lacy, Martha
    Dingli, David
    Fonder, Amie
    Hobbs, Miriam
    Hayman, Suzanne
    Kourelis, Taxiarchis
    Warsame, Rahma
    Muchtar, Eli
    Leung, Nelson
    Kapoor, Prashant
    Gonsalves, Wilson
    Siddiqui, Mustaqeem
    Kyle, Robert
    Rajkumar, Vincent
    Gertz, Morie
    Dispenzieri, Angela
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S125 - S125
  • [22] Infliximab for the Treatment of Neurosarcoidosis: The Mayo Clinic Experience
    Stitt, Derek
    Aksamit, Allen
    Utz, James
    NEUROLOGY, 2016, 86
  • [23] Treatment experience of hidradenitis suppurativa at Mayo Clinic
    Kohorst, John
    Baum, Christian
    Hagen, Clinton
    Davis, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB94 - AB94
  • [24] Preoperative diagnosis and treatment of Mirizzi syndrome
    Giamundo, P
    Esercizio, L
    Mazzotti, A
    Tibaldi, L
    Valente, M
    HAMBURG '97 - EUROPEAN I.H.P.B.A. CONGRESS, 1997, : 427 - 429
  • [25] Atraumatic compartment syndrome: The Mayo Clinic experience.
    Murali, NS
    Bunch, TJ
    Ghosh, A
    Decker, W
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S376 - S376
  • [26] Postural orthostatic tachycardia syndrome: The Mayo Clinic experience
    Thieben, Mark J.
    Sandroni, Paola
    Sletten, David M.
    Benrud-Larson, Lisa M.
    Fealey, Robert D.
    Vernino, Steven
    Lennon, Vanda A.
    Shen, Win-Kuang
    Low, Phillip A.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (03) : 308 - 313
  • [27] Laryngotracheal Amyloidosis: Amyloid Airway Center 23-Year Experience
    Tracy, Lauren F.
    Danis III, D. ONeil
    Rodriggs, Timothy
    Kariveda, Rohith
    Grillone, Gregory A.
    LARYNGOSCOPE, 2024, 134 (04): : 1606 - 1613
  • [28] LONG TERM OUTCOMES OF SACRAL NEUROMODULATION: A 23-YEAR EXPERIENCE
    Gandhi, S.
    Almutairi, S.
    Ali, A.
    Cox, A.
    Gajewski, J.
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S283 - S284
  • [29] A 23-year experience with malignant renal tumors in infancy and childhood
    Tröbs, RB
    Hänsel, M
    Friedrich, T
    Bennek, J
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2001, 11 (02) : 92 - 98
  • [30] Assessment of Cases With Intracranial Hydatid Cyst: A 23-Year Experience
    Turan, Yahya
    Yilmaz, Tevfik
    Gocmez, Cuneyt
    Kamasak, Kagan
    Kemaloglu, Serdar
    Tekin, Recep
    Hattapoglu, Salih
    Bozkaya, Halil
    Caliskan, Alper
    Ceviz, Adnan
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2014, 31 (01): : 90 - 98